Leonardo M Fabbri
Overview
Explore the profile of Leonardo M Fabbri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
202
Citations
10661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuks P, Kole T, Kraft M, Siddiqui S, Fabbri L, Rabe K, et al.
ERJ Open Res
. 2025 Feb;
11(1).
PMID: 39963164
Introduction: Neutrophilic asthma has been suggested to be a clinically distinct phenotype characterised by more severe airflow obstruction and higher exacerbation risk. However, this has only been assessed in few...
2.
Belz D, Putcha N, Alupo P, Siddharthan T, Baugh A, Hopkinson N, et al.
Am J Respir Crit Care Med
. 2024 Oct;
210(11):1300-1307.
PMID: 39405496
No abstract available.
3.
Papi A, Forini G, Maniscalco M, Aliani M, Fabbri L
Eur J Intern Med
. 2024 Aug;
129:131-132.
PMID: 39117553
No abstract available.
4.
Papi A, Forini G, Maniscalco M, Bargagli E, Crimi C, Santus P, et al.
Eur J Intern Med
. 2024 Jul;
128:104-111.
PMID: 38981765
Introduction: Patients with chronic obstructive pulmonary disease (COPD) frequently have cardiovascular comorbidities, increasing the risk of hospitalised COPD exacerbations (H-ECOPDs) or death. This pragmatic study examined the effects of adding...
5.
Kole T, Muiser S, Kraft M, Siddiqui S, Fabbri L, Rabe K, et al.
BMJ Open Respir Res
. 2024 Jun;
11(1).
PMID: 38901877
Background: Asthma is a heterogeneous disease with a prevalence and severity that differs between male and female patients. Question: What are differences between male and female patients with asthma with...
6.
Labaki W, Agusti A, Bhatt S, Bodduluri S, Criner G, Fabbri L, et al.
Am J Respir Crit Care Med
. 2024 Jun;
210(3):281-287.
PMID: 38843079
No abstract available.
7.
Fabbri L, Beghe B, Yasothan U, Kirkpatrick P
Nat Rev Drug Discov
. 2024 May;
23(7):563.
PMID: 38750261
No abstract available.
8.
Beghe B, Spanevello A, Fabbri L
Am J Respir Crit Care Med
. 2024 Feb;
209(8):901-902.
PMID: 38319130
No abstract available.
9.
Price D, Henley W, Cancado J, Fabbri L, Kerstjens H, Papi A, et al.
Pragmat Obs Res
. 2024 Jan;
15:1-16.
PMID: 38274639
Background: Combined ICS and long-acting bronchodilators (LABD) more effectively reduce COPD exacerbations than LABD therapy alone. Corticosteroid-related adverse effects, including pneumonia, limit ICS use. Previous data suggest this risk is...
10.
Fabbri L, Celli B, Agusti A, Criner G, Dransfield M, Divo M, et al.
Lancet Respir Med
. 2023 Sep;
11(11):1020-1034.
PMID: 37696283
Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but...